CBL vs CSX

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

CBL

CTRLBIONIC FPO [CBL]

52MEDIUM

CSX

CLEANSPACE FPO [CSX]

52MEDIUM

Score Breakdown

CBL CSX
Technical
45
53
Catalyst
50
50
Sentiment
50
50
Fundamental
55
95
Momentum
75
59
Risk Gate
47
47

Key Metrics

CBL Metric CSX
$21.4MMarket Cap$38.2M
198KAvg Volume (20d)16K
N/AShort InterestN/A
$0.08652-Week High$0.880
$0.02652-Week Low$0.370
-10.3%Daily Change+0.0%
$0.052Entry Price$0.465
-91.6%ROE+8.8%
-107.0%Profit Margin+8.5%

Active Signals

CBL Signals

RSI drifting toward oversold territory — worth watching
MACD crossed bearish — momentum is fading
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 13.3% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Low cash runway (3 quarters) - dilution risk

CSX Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
MACD momentum is picking up steam
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.8x)
Moderate revenue growth (+10%)
Piotroski F-Score strong (8/9, low-confidence approx)

Ask Scout AI to compare CBL and CSX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CBL Full Analysis → CSX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).